<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04673227</url>
  </required_header>
  <id_info>
    <org_study_id>ThomayerH</org_study_id>
    <nct_id>NCT04673227</nct_id>
  </id_info>
  <brief_title>Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)</brief_title>
  <official_title>Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI) and the Influence of Previous BCG Vaccination - Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomayer University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Thomayer University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      TB-reactive immune cells will be tested in a multiparametric flow cytometry to distinguish an&#xD;
      immune response for antigens of Mycobacterium spp. in TB disease/latent infection or a&#xD;
      reaction after BCG vaccine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this project is the verification of current cytometric panel of detection&#xD;
      antibodies in a wider panel of stimulative immunodominant antigens for CD4+ and CD8+ T cells&#xD;
      in combination with adjuvants 2 in a in vitro activating test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2020</start_date>
  <completion_date type="Anticipated">December 26, 2022</completion_date>
  <primary_completion_date type="Actual">May 26, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Peer-review publication of results of our study</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Creation of new diagnostic tool and his comparision with existing IGRA test (QTF-GP and TST)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>LTBI</condition>
  <condition>BCG Vaccination Reaction</condition>
  <condition>TB</condition>
  <arm_group>
    <arm_group_label>Contact with active TB/ LTBI</arm_group_label>
    <description>After a close contact with bacteriologically confirmed TB suspicion for LTBI with an evidence of previous BCG vaccination status TB confirmed with TST (TST ≥ 5 mm or BCG unvaccinated or TST ≥ 15 mm for BCG vaccinated) 20 children and adolescents 20 adults</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active TB group</arm_group_label>
    <description>Active TB group with positive microbial culture and pathological chest radiography or chest CT 20 children and adolescents 20 adults</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Contact with active TB/ negative</arm_group_label>
    <description>After a close contact with bacteriologically confirmed TB no evidence of TB in TST or IGRA test for 3 months 20 children and adolescents 20 adults</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <description>Blood draw and the analysis of blood in laboratory</description>
    <arm_group_label>Active TB group</arm_group_label>
    <arm_group_label>Contact with active TB/ LTBI</arm_group_label>
    <arm_group_label>Contact with active TB/ negative</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      30 ml of blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study of the broad spectrum of population with the history of having an active TB infection&#xD;
        or close contact with bacteriologically approved pulmonary TB&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: active TB, contact with TB infection in previous 3 months before the&#xD;
        study&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  HIV positive patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Petra Hadlová, MGR</last_name>
    <phone>+724077200</phone>
    <email>Petra.hadlova@natur.cuni.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karolína Doležalová, MD</last_name>
    <phone>+420777246841</phone>
    <email>karolina.dolezalova@ftn.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Science</name>
      <address>
        <city>Prague</city>
        <zip>12800</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petra Hadlová, Mgr.</last_name>
      <phone>+420724077200</phone>
      <email>Petra.hadlova@natur.cuni.cz</email>
    </contact>
    <contact_backup>
      <last_name>Karel Drbal, Doc.</last_name>
      <email>Karel.drbal@natur.cuni.cz</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Thomayer Hospital</name>
      <address>
        <city>Prague</city>
        <zip>14059</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karolína Doležalová, MD</last_name>
      <phone>+420261082337</phone>
      <email>karolina.dolezalova@ftn.cz</email>
    </contact>
    <contact_backup>
      <last_name>Martina Vašáková, Prof</last_name>
      <phone>+261082372</phone>
      <email>Martina.vasakova@ftn.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 12, 2020</study_first_submitted>
  <study_first_submitted_qc>December 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>December 12, 2020</last_update_submitted>
  <last_update_submitted_qc>December 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thomayer University Hospital</investigator_affiliation>
    <investigator_full_name>Karolína Doležalová, M.D.</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Latent Tuberculosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

